Tumor-Fatigue-Sprechstunde der Bayerischen Krebsgesellschaft e. V.

[1]  H. Gruber,et al.  Die Aktualisierung der S3-Leitlinie „Psychoonkologische Diagnostik, Beratung und Behandlung von erwachsenen Krebspatienten“ , 2022, Die Onkologie.

[2]  K. Steindorf,et al.  Diskrepanz zwischen Leitlinien und Versorgungspraxis , 2021 .

[3]  K. Steindorf,et al.  Knowledge, perceptions, and management of cancer-related fatigue: the patients' perspective , 2020, Supportive Care in Cancer.

[4]  J. Dowds,et al.  Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection , 2020, medRxiv.

[5]  F. Roila,et al.  Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  E. Schneider,et al.  Tumor-Fatigue-Sprechstunde der Bayerischen Krebsgesellschaft e.V. , 2017, Forum.

[7]  G. Schlimok,et al.  Consultation Program for Patients with Cancer-Related Fatigue: A Systematic Evaluation of the Experiences of the Bavarian Cancer Society , 2016, Oncology Research and Treatment.

[8]  I. Fischer,et al.  Tumor-Fatigue Sprechstunde der BKG e.V. , 2016, Forum.

[9]  K. Olson,et al.  The biology of cancer-related fatigue: a review of the literature , 2015, Supportive Care in Cancer.

[10]  M. Morris,et al.  Cancer-related fatigue: a survey of health practitioner knowledge and practice , 2015, Supportive Care in Cancer.

[11]  T. Oliver,et al.  A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. , 2013, Current oncology.

[12]  D. Torgerson,et al.  Sample size calculations for pilot randomized trials: a confidence interval approach. , 2013, Journal of clinical epidemiology.

[13]  J. Weis.  Diagnostik und Erfassung der tumorassoziierten Fatigue , 2013, Forum.

[14]  F. Dimeo,et al.  Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. , 2012, Deutsches Arzteblatt international.

[15]  F. Petermann†,et al.  Tumorbedingte Fatigue , 2011, Der Onkologe.

[16]  K. Papsdorf,et al.  Prädiktoren tumorassoziierter Fatigue , 2011 .

[17]  J. Stolzenburg,et al.  Fatigue in Cancer Survivors – Prevalence and Correlates , 2009, Oncology Research and Treatment.

[18]  C. Cleeland,et al.  Assessment of clinical relevant fatigue level in cancer , 2007, Supportive Care in Cancer.

[19]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[20]  C. Escalante,et al.  A cancer-related fatigue clinic: opportunities and challenges. , 2003, Journal of the National Comprehensive Cancer Network : JNCCN.

[21]  C. Cleeland,et al.  Validation of the German version of the brief fatigue inventory. , 2003, Journal of pain and symptom management.

[22]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[23]  D. Cella,et al.  Progress toward guidelines for the management of fatigue. , 1998, Oncology.

[24]  Chad A. LaGrange,et al.  NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .

[25]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[26]  Philipp Mayring,et al.  Kombination und Integration qualitativer und quantitativer Analyse , 2001 .